ArticleRadiologia brasileira
Quantitative MRI assessment in metabolic dysfunctionassociated steatotic liver disease: correlation between the MRI-PDFF and liver size.
Article in Radiologia brasileira. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Noninvasive Assessment of Hepatic Steatosis in Living Liver Donors.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the relationship between the magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF) and liver size in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), as well as to explore the role of determining the craniocaudal diameter of the right hepatic lobe (CCDHL), measured at the midclavicular line, and liver volumetry as complementary tools in the assessment of hepatic steatosis. Materials and Methods: This was a single-center, cross-sectional, prospective study including 289 patients with MASLD who underwent multiparametric MRI for the evaluation of hepatic steatosis, which was categorized by the MRI-PDFF value. Liver size measurements included the CCDHL, liver volume from automated segmentation, and its difference from the total expected liver volume (eLV), calculated with the Vauthey formula. Results: A significant positive correlation was observed between the MRI-PDFF and liver size measurements, including the CCDHL (rs = 0.651; Conclusion: The integrated assessment of the MRI-PDFF and liver size appears to be effective for the diagnosis, stratification, and monitoring of steatosis in patients with MASLD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.